The application of information technology to regional, national, and global surveillance of antimicrobial Resistance : Infectious DiseasesSAHM, Daniel F; THORNSBERRY, Clyde; KARLOWSKY, James A et al.Current pharmaceutical design. 2003, Vol 9, Num 12, pp 969-974, issn 1381-6128, 6 p.Article

Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysisGUPTA, Kalpana; SAHM, Daniel F; MAYFIELD, David et al.Clinical infectious diseases. 2001, Vol 33, Num 1, pp 89-94, issn 1058-4838Article

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoinKARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 2, pp 183-187, issn 1058-4838, 5 p.Article

Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001KARLOWSKY, James A; JONES, Mark E; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1672-1680, issn 0066-4804, 9 p.Article

In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendationsSAHM, Daniel F; THORNSBERRY, Clyde; MAYFIELD, David C et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 2, pp 669-674, issn 0095-1137Article

Five-Year Longitudinal Assessment (2008 to 2012) of E-101 Solution Activity against Clinical Target and Antimicrobial-Resistant PathogensDENYS, Gerald A; PILLAR, Chris M; SAHM, Daniel F et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4911-4914, issn 0066-4804, 4 p.Article

Monitoring Antibiotic Resistance in Ocular Microorganisms: Results From the Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) 2009 Surveillance StudyHAAS, Wolfgang; PILLAR, Chris M; TORRES, Mohana et al.American journal of ophthalmology. 2011, Vol 152, Num 4, pp 567-574, issn 0002-9394, 8 p.Article

Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States : findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance ProgramsPILLAR, Chris M; DRAGHI, Deborah C; SHEEHAN, Daniel J et al.Diagnostic microbiology and infectious disease. 2008, Vol 60, Num 2, pp 221-224, issn 0732-8893, 4 p.Article

Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United statesMINGGUI WANG; SAHM, Daniel F; JACOBY, George A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1295-1299, issn 0066-4804, 5 p.Article

In Vitro Activity of Tigecycline against Gram-Positive and Gram-Negative Pathogens as Evaluated by Broth Microdilution and EtestPILLAR, Chris M; DRAGHI, Deborah C; DOWZICKY, Michael J et al.Journal of clinical microbiology (Print). 2008, Vol 46, Num 9, pp 2862-2867, issn 0095-1137, 6 p.Article

In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European originPILLAR, Chris M; ARANZA, Mohana K; SHAH, Dineshchandra et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 61, Num 3, pp 595-602, issn 0305-7453, 8 p.Article

In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United StatesPILLAR, Chris M; TORRES, Mohana K; BROWN, Nina P et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 12, pp 4388-4399, issn 0066-4804, 12 p.Article

Bactericidal activity and resistance development profiling of dalbavancinGOLDSTEIN, Beth P; DRAGHI, Deborah C; SHEEHAN, Daniel J et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 4, pp 1150-1154, issn 0066-4804, 5 p.Article

Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaximeKARLOWSKY, James A; JONES, Mark E; DRAGHI, Deborah C et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 10, pp 3155-3160, issn 0066-4804, 6 p.Article

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesKARLOWSKY, James A; KELLY, Laurie J; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 8, pp 2540-2545, issn 0066-4804Article

Multidrug-resistant urinary tract isolates of Escherichia coli : Prevalence and patient demographics in the United States in 2000SAHM, Daniel F; THORNSBERRY, Clyde; MAYFIELD, David C et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 5, pp 1402-1406, issn 0066-4804Article

Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005ASBELL, Penny A; SAHM, Daniel F; SHAW, Mary et al.Journal of cataract and refractive surgery. 2008, Vol 34, Num 5, pp 814-818, issn 0886-3350, 5 p.Article

Current antimicrobial resistance profiles among methicillin-resistant Staphylococcus aureus encountered in the outpatient settingDRAGHI, Deborah C; SHEEHAN, Daniel F; HOGAN, Patricia et al.Diagnostic microbiology and infectious disease. 2006, Vol 55, Num 2, pp 129-133, issn 0732-8893, 5 p.Article

Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001JOHNSON, James R; KUSKOWSKI, Michael A; GALEWSKI, Abby et al.The Journal of infectious diseases. 2004, Vol 190, Num 10, pp 1739-1744, issn 0022-1899, 6 p.Article

Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000DAVIES, Todd A; EVANGELISTA, Alan; PFLEGER, Sharon et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 1, pp 119-124, issn 0066-4804Article

Longitudinal analysis of the in vitro activity profile of oritavancin and comparator glycopeptides against Gram-positive organisms from Europe: 2005-2008ARHIN, Francis F; MOECK, Gregory; DRAGHI, Deborah C et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 5, pp 474-476, issn 0924-8579, 3 p.Article

In vitro activity of linezolid against key gram-positive organisms isolated in the United States : Results of the LEADER 2004 surveillance programDRAGHI, Deborah C; SHEEHAN, Daniel J; HOGAN, Patricia et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 12, pp 5024-5032, issn 0066-4804, 9 p.Article

Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnrMINGGUI WANG; SAHM, Daniel F; JACOBY, George A et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 4, pp 1400-1401, issn 0066-4804, 2 p.Article

In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-Negative bacilliCRITCHLEY, Ian A; SAHM, Daniel F; KELLY, Laurie J et al.Chemotherapy (Basel). 2003, Vol 49, Num 1-2, pp 44-48, issn 0009-3157, 5 p.Article

Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parametersARHIN, Francis F; TOMFOHRDE, Karla; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2008, Vol 62, Num 1, pp 92-95, issn 0732-8893, 4 p.Article